Abstract
Metamizole is a powerful analgesic drug whose varying regulatory status from country to country reflects its mixed benefit-risk profile. Patients must be instructed about the risk of agranulocytosis and the symptoms by which it can be recognized early.
Related Publications
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
PURPOSE Most patients with advanced pancreas cancer experience pain and must limit their daily activities because of tumor-related symptoms. To date, no treatment has had a sign...
Virtual colonoscopy for colorectal cancer screening: current status
Computed tomography colonography (CTC) (also known as 'virtual colonoscopy') is a noninvasive method of imaging the colon using helical CT. Although CTC has been shown to be use...
Physical activity and lipoprotein metabolism: epidemiological evidence and clinical trials.
Prospective epidemiological studies have proven a close link between the lipoprotein profile and cardiovascular morbidity and mortality. As physical activity is accepted as a si...
National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000
The panel concludes that decisions regarding adjuvant hormonal therapy should be based on the presence of hormone receptor protein in tumor tissues. Adjuvant hormonal therapy sh...
Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes
The benefits of previously improved blood-pressure control were not sustained when between-group differences in blood pressure were lost. Early improvement in blood-pressure con...
Publication Info
- Year
- 2026
- Type
- article
- Issue
- Forthcoming
- Citations
- 0
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
0
OpenAlex
Cite This
Ingolf Cascorbi,
Ralf Baron
(2026).
Metamizole: Indications and Risks..
PubMed
(Forthcoming)
.
https://doi.org/10.3238/arztebl.m2025.0214
Identifiers
- DOI
- 10.3238/arztebl.m2025.0214